0000899243-19-018521.txt : 20190628
0000899243-19-018521.hdr.sgml : 20190628
20190628160543
ACCESSION NUMBER: 0000899243-19-018521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190626
FILED AS OF DATE: 20190628
DATE AS OF CHANGE: 20190628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siu Christine
CENTRAL INDEX KEY: 0001743029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 19929271
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-26
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001743029
Siu Christine
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO
CA
94104
0
1
0
0
CFO and Secretary
Common Stock
2019-06-26
4
M
0
17000
0.59
A
36470
D
Stock Option (right to buy)
0.59
2019-06-26
4
M
0
17000
0.00
D
2027-12-21
Common Stock
17000
222191
D
The shares subject to this option vest and become exercisable in 48 equal monthly installments after December 1, 2017, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
/s/ Franco Valle , Attorney-in-Fact
2019-06-28